Skip to content

Evaluation of clinical efficacy of electroacupuncture in the treatment of chronic atrophic gastritis

Evaluation of clinical efficacy of electroacupuncture in the treatment of chronic atrophic gastritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000707
Enrollment
Unknown
Registered
2024-11-14
Start date
2023-11-23
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic atrophic gastritis

Interventions

Dummy acupuncture + Western medicine control group: In addition to Western medicine treatment, complementary acupuncture therapy is also used.
electroacupuncture treatment group:After selecting the acupoints, the electric needles are connected to Zhongyuan and the left Zusanli.
electroacupuncture and western medicine treatment group:In addition to Western medicine treatment, acupuncture on the stomach meridian points is also used.
western medicine control group:Omeprazole by mouth

Sponsors

The First Affiliated Hospital of Anhui University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria; (2) Age 18-75 years old gender is not limited; (3) have not taken drugs to improve gastrointestinal function recently; (4) Patient's informed consent

Exclusion criteria

Exclusion criteria: 1 Does not meet the inclusion criteria 2 Combined with organic diseases of digestive system 3 Patients with mental illness systemic infectious diseases and malignant tumors 4 Patients with serious heart brain and kidney diseases 5 Pregnant or lactating women and those who planned to become pregnant during the study period 6 Take other therapeutic drugs 2 weeks before treatment 7 There are other major organ diseases 8 Patients with contraindications for acupuncture therapy 9 Poor compliance can not cooperate with the treatment as required

Design outcomes

Primary

MeasureTime frame
TCM syndrome integral scale of gastrointestinal diseases;Histopathological score;Gastroelectricity;

Secondary

MeasureTime frame
Translated SF-36 scale;Specificity of acupoints;Gastric receptivity and emptying function;Hamilton Depression and anxiety Scale;

Countries

China

Contacts

Public ContactFan Yinqiu

The First Affiliated Hospital of Anhui University of Chinese Medicine

804472362@qq.com+86 137 2102 1853

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026